Company Filing History:
1 out of 40 
1 out of 156 Years Active: 2005-2008
Title: Discovering the Innovations of Timothy N C Wells
Introduction
Timothy N C Wells, an accomplished inventor based in Prevessin Moens, France, has made significant contributions in the field of pharmaceuticals, particularly in the treatment of multiple sclerosis and transplant rejection. With a total of two patents to his name, Wells is recognized for his innovative approaches to complex medical issues.
Latest Patents
Wells' latest patents showcase his pioneering work on chemokine mutants and their applications. The first patent, titled "Chemokine mutants in the treatment of multiple sclerosis," details mutants of CC chemokines that possess at least two mutations in the cationic site of the 40's loop. This innovation reduces GAG-binding activity compared to the wild-type molecule. Research has indicated that these mutated chemokines are effective in treating multiple sclerosis and other demyelinating diseases, with a triple mutant of RANTES demonstrating the most promising results.
The second patent, "Chemokine receptor antagonist and cyclosporin in combined therapy," introduces the use of a chemokine receptor antagonist in conjunction with cyclosporin to create a pharmaceutical composition aimed at preventing or treating the rejection of transplanted organs, tissues, or cells. This composition allows for the simultaneous, separate, or sequential use of its active ingredients, highlighting a particular focus on the effectiveness of Met-RANTES combined with cyclosporin A in treating renal allograft transplant rejection.
Career Highlights
Throughout his career, Timothy N C Wells has worked with notable companies such as Laboratoires Serono S.A. and Applied Research Systems Holding N.V. These experiences have greatly influenced his research and innovations in the pharmaceutical field, solidifying his reputation as a leading inventor in his area of expertise.
Collaborations
Wells has collaborated with esteemed colleagues, including Amanda Proudfoot and Marie Kosco-Vilbois. Their collective efforts have contributed to advancing research and developing pharmaceutical compositions that address significant medical challenges.
Conclusion
Timothy N C Wells exemplifies the spirit of innovation within the pharmaceutical industry. His patents reflect a deep understanding of biologically active compounds and their therapeutic potentials. With ongoing research and collaboration, Wells continues to pave the way for future advancements in medicine.